Literature DB >> 28670053

The Everyday Cognition Scale in Parkinson's disease.

Rachel A Cooper1, Jared Benge1, Crystal Lantrip1, Michael J Soileau1.   

Abstract

This brief report describes caregiver ratings on the Everyday Cognition (ECog) scale, a psychometrically robust measure of cognitively driven daily activities that was initially designed for other neurodegenerative conditions, in individuals with Parkinson's disease (PD). In 49 individuals with PD, those with suspected PD dementia had more difficulties across ECog domains than those with normal cognition or mild cognitive impairment. Results from multiple regression analyses revealed that activities captured by the ECog were related to measured cognitive ability, over and above disease duration and demographic factors. The lack of floor and ceiling effects speaks to the potential utility of the instrument in practice and research regarding this population. Preliminary data support the utility of the ECog as a marker of functional impact of cognitive problems in PD, though further research will be required to validate the instrument in this population.

Entities:  

Year:  2017        PMID: 28670053      PMCID: PMC5468009          DOI: 10.1080/08998280.2017.11929611

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  12 in total

1.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  The measurement of everyday cognition (ECog): scale development and psychometric properties.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Deborah Cahn-Weiner; William Jagust; Kathleen Baynes; Charles Decarli
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

Review 4.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

Review 5.  Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtable.

Authors:  Jamie Eberling; Lona Vincent; Jennifer G Goldman; Daniel Weintraub; Jaime Kulisevsky; Connie Marras; Glenn Stebbins; Karl Kieburtz
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

6.  Deficits in Everyday Function Differ in AD and FTD.

Authors:  Lovingly Q Park; Danielle Harvey; Julene Johnson; Sarah T Farias
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Oct-Dec       Impact factor: 2.703

7.  The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Authors:  J C Dalrymple-Alford; M R MacAskill; C T Nakas; L Livingston; C Graham; G P Crucian; T R Melzer; J Kirwan; R Keenan; S Wells; R J Porter; R Watts; T J Anderson
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

8.  Longitudinal trajectories of everyday function by diagnostic status.

Authors:  Sarah Tomaszewski Farias; Elizabeth Chou; Danielle J Harvey; Dan Mungas; Bruce Reed; Charles DeCarli; Lovingly Quitania Park; Laurel Beckett
Journal:  Psychol Aging       Date:  2013-12

9.  Everyday cognition in prodromal Huntington disease.

Authors:  Janet K Williams; Ji-In Kim; Nancy Downing; Sarah Farias; Deborah L Harrington; Jeffrey D Long; James A Mills; Jane S Paulsen
Journal:  Neuropsychology       Date:  2014-07-07       Impact factor: 3.295

10.  Informant Perceptions of the Cause of Activities of Daily Living Difficulties in Parkinson's Disease.

Authors:  Jared F Benge; Steve Balsis
Journal:  Clin Neuropsychol       Date:  2016-02-03       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.